23andMe
limited use of data and lack of patient engagement constrains productivity drug development is inefficient | 23andMe
Company
Deck Type
Sector
Industry
Deck date
February 2021
Slide
26 of 47
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
August 2022
limited use of genetic data and lack of patient engagement constrain productivity drug development is inefficient | 23andMe
Investor Presentation
February 2022
limited use of genetic data and lack of patient engagement constrain productivity drug development is inefficient | 23andMe
Investor Day
January 2022
limited use of genetic data and lack of patient engagement constrain productivity drug development is inefficient | 23andMe
Related slides by other companies
Equillium
Investor Presentation
August 2023
driving development towards option decision two data deliverables expected in a | Equillium
Certara
Investor Day
December 2021
simulator framework with virtual patients | Certara
Equillium
Investor Presentation
November 2023
driving development towards option decision two data deliverables expected in | Equillium
Babylon
SPAC
July 2021
using patient data and insights to create personalized care plans | Babylon
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io